Human embryonic stem cells (hESCs) are capable of unlimited self-renewal, a process to reproduce self, and retain the ability to differentiate into all cell types in the body. Therefore, hESCs…
Human embryonic stem cells (hESCs) are pluripotent entities, capable of generating a whole-body spectrum of distinct cell types. We have developmental procedures for inducing hESCs to develop into pure populations…
Alzheimer’s Disease (AD) is a progressive incurable disease that robs people of their memory and ability to think and reason. It is emotionally, and sometimes financially devastating to families that…
Facioscapulohumeral muscular dystrophy (FSHD) is the third most common hereditary muscular dystrophy. It is autosomal dominant, meaning that if one of the parents has the disease, their children have a…
One of the main objectives of stem cell biology is to create physiologically relevant cell types that can be used to either facilitate the study of or directly treat human…
*Please note: this video contains graphic images of a disfiguring disease John Wagner presented the closing scientific talk at the 2011 CIRM Grantee Meeting. Weaving together stories of medical history,…
Spotlight on Disease Team Awards - Genetic Skin Disease: Welcoming Remarks Robert Klein J.D., gave the welcoming remarks for the "Spotlight on Disease Team Awards: Genetic Skin Disease," an educational…
Spotlight on Disease Team Awards - Genetic Skin Disease: Introduction Phillip Pizzo, M.D., spoke at the "Spotlight on Disease Team Awards: Genetic Skin Disease," an educational event presented at the…
Spotlight on Disease Team Awards - Genetic Skin Disease: Lynn Anderson Lynn Anderson, spoke at the "Spotlight on Disease Team Awards: Genetic Skin Disease," an educational event presented at the…
Spotlight on Disease Team Awards - Genetic Skin Disease: Albert Lane Albert Lane, M.D., spoke at the "Spotlight on Disease Team Awards: Genetic Skin Disease," an educational event presented at…
Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox.
